Thomas Levato is a partner in Goodwin Procter’s Technology Companies & Life Sciences Group and a member of its Capital Markets and FinTech Practices. He has extensive experience representing investment banks, issuers and investors in capital markets transactions, including IPOs, follow-on offerings, rights offerings and private placements of equity, equity-linked and debt securities.

Mr. Levato is a market leader in alternative financing transactions, including Confidentially Marketed Public Offerings (CMPOs), Registered Direct Offerings (RDs), Private Investments in Public Equity (PIPEs) and At-the-Market Offerings (ATMs). Goodwin Procter is consistently ranked as one of the most active law firms in the United States advising on these transactions.

Mr. Levato also routinely counsels clients on corporate governance matters, federal and state securities law issues and rules and interpretations of the Financial Industry Regulatory Authority and various trading markets including the NYSE and NASDAQ.